May 21, 2019 / 06:30PM GMT
Kevin Caliendo - UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution
Good afternoon, everybody. I'm Kevin Caliendo, the healthcare IT and supply chain analyst here at UBS, and we are very happy to have Steve Rusckowski, the CEO -- President, CEO and Chairman of Quest Diagnostics with us today.
Steve, thank you very much for coming. I don't know if you want to give a couple of minutes and talk a little bit about where the business is right now.
Stephen H. Rusckowski - Quest Diagnostics Incorporated - Former Executive Chairman
Sure, sure. We're going through an interesting transition. I'm sure we'll get a few questions from the audience on this. And this is the transition we think that has never been seen before in our industry, where really there's 3 changes that are happening. One is we're having the worst cut we've ever had from Medicare. And that was put in place with a bill called PAMA. Some of you that follow us know about that. And our math says it's going to take out around half the profit in the
Quest Diagnostics Inc at UBS Global Healthcare Conference Transcript
May 21, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers